ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02050529
Recruitment Status : Unknown
Verified January 2014 by Saima Aziz Siddiqui, Dow University of Health Sciences.
Recruitment status was:  Recruiting
First Posted : January 30, 2014
Last Update Posted : January 30, 2014
Sponsor:
Information provided by (Responsible Party):
Saima Aziz Siddiqui, Dow University of Health Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : February 2014
  Estimated Study Completion Date : March 2014